Educational Areas/Call for Grants


 

Areas of Educational Interest Available Funding Call for Grants
Cardiovascular
Acute Coronary Syndrome  
Coagulation Therapy  
High Risk Prior Myocardial Infarction  
Hypertriglyceridemia  
Heart Failure – SGLT2 Inhibition  
Secondary Prevention Acute Ischemic Stroke  
INFECTIONS & VACCINES
SARS-CoV-2 Monoclonal Antibodies  
SARS-CoV-2 Vaccine  
Nephrology
Chronic Kidney Disease - Anemia  
Chronic Kidney Disease – SGLT2 Inhibition  
Hyperkalemia CGA Nephrology Hyperkalemia 2022
Oncology
Advanced Breast Cancer
BRCA CGA Oncology Breast Cancer BRCA 2022
Non-BRCA  
DNA Damage Response  
PARP Inhibition  
HER2+ CGA ONC Breast Cancer HER2 2022 Pathology
Metastatic HR+  
Cervical Cancer
Locally Advanced Cervical Cancer (LACC)  
Gastric Cancer
Gastric Cancer - HER2+  
Hematology
CLL (Chronic Lymphocytic Leukemia)  
MCL (Mantle Cell Lymphoma)  
DLBCL (Diffuse Large B-Cell Lymphoma)  
Immuno-Oncology
Biliary Track Cancer (BTC)                       
Bladder Cancer  
Endometrial Cancer                        
HCC (Hepatocellular Carcinoma)

                        
Non-Small Cell Lung Cancer (NSCLC)                      

CGA_Immuno-Oncology_III_NSCLC_2022

CGA Immuno-Oncology_Stage_IV_NSCLC_2022.pdf

Small Cell Lung Cancer (SCLC)                         
Neurofibromatosis
Neurofibromatosis Type 1  
Plexiform Neurofibromas  
Non-Small Cell Lung Cancer
EGFR Diagnostics & Plasma Testing  
EGFRm NSCLC  
HER2+ NSCLC  
TROP2 NSCLC                        
Ovarian Cancer
BRCA  
Non-BRCA  
PARP Inhibition  
DNA Damage Response  
Pancreatic Cancer
BRCA  
DNA Damage Response  
PARP Inhibition  
Prostate Cancer (mCRPC)
DNA Damage Response  
Homologus Recombination Repair  
PARP Inhibition  
Respiratory
Asthma (EX-US only)  
Chronic Cough (EX-US only)  
COPD

 

CRSwNP (limited budget)  
Eosinophilic Esophagitis (limited budget)  
Severe Asthma (CGAs for US Only)

 

Rheumatology/Immunology/Autoimmune
Systemic Lupus Erythematosus
(limited budget)
 
R & D Discovery
Scientific or educational activities designed to educate research scientists, principal researchers, drug development professionals, academics, pre-doctoral students, doctoral students and fellows. These programs must be educational and non-promotional in nature and planned, designed and implemented in accordance with the U.S. Food and Drug Administration's Guidance on Industry-Supported Scientific and Educational Activities.